A multicomponent quality improvement strategy combining electronic decision support, care coordinators, patient education, text reminders, and provider feedback significantly improved medication adherence and lifestyle changes in 410 Indian heart patients. According to Gram Research analysis, patients receiving this coordinated approach were 45% more likely to take heart attack medications correctly and 2.4 times more likely to take stroke medications as prescribed compared to usual care.
Researchers in India tested a new way to help patients with heart disease, stroke, and heart failure stick to their treatment plans. The strategy combined computer tools for doctors, nurse coordinators, text message reminders, and patient education classes. When tested with 410 patients at four hospitals, the approach worked well. More patients took their medications as prescribed, ate healthier diets, and exercised regularly. According to Gram Research analysis, this multicomponent quality improvement strategy shows promise for improving how well heart patients follow medical advice in India and potentially other countries.
Key Statistics
A 2026 randomized controlled trial of 410 patients in India found that a multicomponent quality improvement strategy increased correct medication use for heart attack patients from 32% to 58%, a 45% relative improvement.
In the same 2026 trial, stroke patients receiving coordinated care were 2.4 times more likely to take their medications as prescribed, with 77% adherence versus 32% in usual care.
A 2026 feasibility trial of 410 Indian heart patients showed that physical activity adherence jumped from 70% to 91% with a multicomponent quality improvement strategy, a 23% relative increase.
The 2026 C-QIP trial demonstrated 93% retention rates in the intervention group and 94% fidelity in delivering lifestyle counseling, indicating high feasibility and acceptability of the multicomponent strategy.
The Quick Take
- What they studied: Whether a combination of five different support tools could help heart patients in India better follow their doctor’s treatment recommendations and take their medications correctly.
- Who participated: 410 adults with heart disease, stroke, or heart failure from four hospitals in India (both public and private). Patients were randomly assigned to either receive the new support strategy or continue with regular care.
- Key finding: Patients who received the new strategy were significantly more likely to take their heart medications as prescribed (91% versus 82%), eat healthy diets (92% versus 82%), and exercise regularly (91% versus 70%). For heart attack and stroke patients specifically, medication use nearly doubled.
- What it means for you: If you have heart disease or stroke, a coordinated care approach with reminders, education, and provider support tools may help you stick to your treatment plan better. However, this was a feasibility study, so larger trials are needed before this becomes standard practice everywhere.
The Research Details
This was a pragmatic feasibility randomized controlled trial, which means researchers tested whether a new approach could actually work in real hospital settings with real patients. Half of the 410 patients received the new multicomponent strategy called C-QIP, while the other half received standard care. The C-QIP strategy included five components: electronic decision support tools that helped doctors choose the right medications, non-physician care coordinators (like nurses or health workers) who helped manage patient care, patient education classes, text message reminders sent to patients’ phones, and regular feedback to doctors about how well their patients were doing.
Patients were followed for about 15 months on average. The researchers measured whether the program was actually feasible to run, whether patients and doctors accepted it, whether it was done correctly (called fidelity), and whether it improved how well patients followed their treatment plans and took their medications.
This type of study design is important because it tests whether a new approach can actually work in the real world before investing in larger, more expensive trials. The researchers chose hospitals in India specifically because heart disease care quality there is often below recommended standards, making it an important place to test improvements.
Testing new care strategies in real hospital settings is crucial because what works in controlled research environments doesn’t always work when doctors and patients are busy in everyday practice. This study shows that a coordinated approach combining technology, human support, education, and reminders can actually be delivered successfully and accepted by both patients and healthcare providers in India’s healthcare system.
The study had strong retention rates, with 93% of the intervention group and 92% of the usual care group completing the study. The intervention was delivered with high fidelity, meaning 94% of patients in the C-QIP group received the lifestyle counseling as planned. The study was published in PLoS Medicine, a highly respected peer-reviewed journal. However, this was a feasibility study rather than a large confirmatory trial, so it was not powered to detect differences in major health outcomes like heart attacks or deaths. The researchers also note that individual randomization within shared clinics could have allowed some information sharing between groups.
What the Results Show
The C-QIP strategy proved feasible and acceptable. Nearly all patients who started the program completed it, and the program components were delivered as intended. The strategy significantly improved how well patients took their heart medications. For patients with ischemic heart disease (heart attacks), 58% of those in the C-QIP group took their medications as prescribed compared to only 32% in usual care, a 45% relative increase. For stroke patients, the difference was even more dramatic: 77% in the C-QIP group took medications correctly versus 32% in usual care, nearly a 2.4 times higher rate.
Patients in the C-QIP group also reported much better adherence to lifestyle changes. About 91% reported taking medications correctly versus 82% in usual care. For diet adherence, 92% in the C-QIP group followed dietary recommendations versus 82% in usual care. Physical activity showed the biggest difference: 91% of C-QIP patients reported exercising regularly compared to only 70% in usual care, a 23% relative improvement.
Interestingly, the strategy did not significantly improve medication use for heart failure patients, though the reasons for this are unclear and warrant further investigation. The study did not measure major health outcomes like heart attacks, strokes, or deaths, as it was designed as a feasibility study rather than a large clinical trial.
Beyond medication and lifestyle adherence, the study found that the C-QIP strategy improved various care processes. Patients received more guideline-directed medical therapy overall, meaning they were prescribed medications that major medical organizations recommend for their conditions. The text message reminders appeared to be well-received by patients, and the non-physician care coordinators successfully helped manage patient care alongside doctors. Patient education sessions were well-attended and completed.
This study builds on previous research showing that quality improvement strategies can help in other countries and healthcare settings. However, most previous studies were conducted in wealthy countries with different healthcare systems. This trial is important because it demonstrates that a multicomponent approach can work in India’s healthcare system, where resources are often more limited. The findings align with research showing that combining multiple support strategies (technology, education, reminders, and human coordination) works better than any single approach alone.
The researchers acknowledge several important limitations. First, this was a feasibility study designed to test whether the approach could work, not a large trial designed to prove it reduces heart attacks, strokes, or deaths. Second, patients were randomly assigned as individuals but treated at shared clinics, which means some information about the intervention may have spread to the usual care group. Third, the study relied on patient self-reports of medication and diet adherence rather than objective measurements, which can be less accurate. Fourth, the study was not large enough to analyze whether the strategy worked differently for different groups of patients. Finally, the follow-up period of 15 months is relatively short for detecting major health events.
The Bottom Line
If you have heart disease, stroke, or heart failure, ask your healthcare provider about coordinated care programs that combine medication reminders, education, and care coordination support. These approaches appear to help patients stick to their treatment plans better. However, this is still early-stage research, and larger studies are needed to confirm whether these improvements in medication adherence actually translate to fewer heart attacks, strokes, or deaths. Confidence level: Moderate for improving adherence; Low for preventing major health events.
This research is most relevant for patients with heart disease, stroke, or heart failure, especially those who struggle to remember to take medications or follow lifestyle recommendations. Healthcare systems and hospitals in India and other countries with similar resources should pay attention to this approach. Policymakers considering how to improve chronic disease care should consider testing multicomponent strategies. People without cardiovascular disease don’t need to apply these findings directly, but the approach may eventually be adapted for other chronic conditions.
Based on this study, improvements in medication adherence and lifestyle changes appeared within the 15-month follow-up period. However, it typically takes several years to see major reductions in heart attacks, strokes, or deaths from improved adherence. Patients should expect to see changes in their daily habits and medication compliance within weeks to months, but major health benefits would take longer to measure.
Frequently Asked Questions
What is a multicomponent quality improvement strategy for heart disease?
It combines five support tools: computer systems that help doctors choose correct medications, care coordinators who manage patient care, education classes, text message reminders, and regular feedback to doctors. This 2026 trial of 410 patients showed it improved medication adherence by 45% for heart attack patients.
Can text message reminders really help me take my heart medications?
Yes. In this 2026 Indian trial, patients receiving text reminders combined with other support tools showed 91% medication adherence versus 82% in usual care. The reminders work best as part of a coordinated care approach, not alone.
Does this strategy work for all types of heart disease?
It worked well for heart attack and stroke patients, but not significantly for heart failure in this trial. Researchers aren’t sure why heart failure patients didn’t benefit as much, so more research is needed to understand this difference.
How long does it take to see benefits from this type of care program?
Improvements in medication adherence and lifestyle changes appeared within the 15-month study period. However, major health benefits like fewer heart attacks or strokes typically take years to measure and require longer follow-up studies.
Is this approach available in my country or hospital?
This strategy was tested in India and may not yet be widely available elsewhere. However, the 2026 trial shows it’s feasible and effective, so hospitals and healthcare systems may begin implementing similar programs based on these results.
Want to Apply This Research?
- Track daily medication adherence by logging each dose taken, weekly diet adherence by recording meals that follow your doctor’s recommendations, and weekly physical activity minutes. Set a specific goal like 150 minutes of moderate activity per week.
- Enable push notifications for medication reminders at the same time each day, use the app to log meals and get feedback on dietary choices, and set weekly exercise goals with progress tracking. Connect with a virtual care coordinator through the app for questions about your treatment plan.
- Review your medication adherence percentage weekly, track trends in diet and exercise compliance monthly, and share reports with your healthcare provider at each visit. Use the app to identify patterns in when you miss doses or skip healthy behaviors, then adjust reminders or routines accordingly.
This research demonstrates the feasibility and acceptability of a quality improvement strategy for heart disease care in India, with improvements in medication adherence and lifestyle changes. However, this was a feasibility trial not designed to measure major health outcomes like heart attacks, strokes, or deaths. The findings should not replace professional medical advice. Always consult your healthcare provider before making changes to your treatment plan or starting new medications. This strategy may not be available at all hospitals or in all countries. Individual results may vary based on personal health circumstances, other medical conditions, and adherence to the program.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.